The National Comprehensive Cancer Network® (NCCN®) works in collaboration with third party organizations to present the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) to international audiences of clinicians and other medical professionals. Additionally, NCCN collaborates to create and distribute International Adaptations and Translations of the NCCN Guidelines®, which may include modifications representative of metabolic differences in populations, technological considerations, and regulatory status of agents used in cancer management, such as availabilities of drugs, biologics, devices, and procedures. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients with cancer can live better lives.
The continued emergence of the NCCN Guidelines® as the global standard for clinical policy in oncology was reflected in the growing number and scope of invitations for NCCN to present to international audiences.
NCCN has presented the NCCN Guidelines and supporting data at interactive educational programs in
On the global stage, NCCN addresses areas such as screening, staging, and therapeutic strategies for tumor types as well as supportive care options. Multidisciplinary management approaches to certain oncologic diseases were discussed by medical oncologists, surgical oncologists, and radiation oncologists from world-recognized NCCN Member Institutions and leading foreign cancer centers. Additionally, regional experts presented information about their patient populations and respective management approaches to the disease states.
Demand has also increased for the development and publication of foreign editions of the NCCN Guidelines. These resources include adaptations accounting for metabolic differences in populations, accessibility of technology, and regulatory status of health care technologies used in cancer management in the specified country. The foreign editions of NCCN Guidelines are developed by the host country’s oncology thought leaders in conjunction with NCCN Guidelines Panel Members. Modified NCCN Guidelines are published and distributed locally to aid clinicians in determining appropriate and effective avenues of care.
As a final note, approximately 47% of registered users of the NCCN Guidelines®, NCCN Drugs & Biologics Compendium (NCCN Compendium®), and NCCN Chemotherapy Order Templates (NCCN Templates®) reside outside the United States, illustrating that the interest and implementation of NCCN resources in the global community continues to flourish.
* As of January 1, 2012, NCCN will no longer be affiliated with EMD Scientific Communications Group, including the legal entities EMD China Scientific Communication (Beijing) Ltd., Beijing, EMD Scientific Communication (Shanghai Branch) Ltd., EMD Asia Scientific Communication Ltd., EMD China Scientific Communication Ltd., EMD Scientific Network Corporation (China) Ltd., and EMD Asia Scientific Communication (Taiwan Branch) Co. Ltd., (collectively, “EMD”) in any capacity and, effective on that date, EMD will have relinquished any and all previous licenses to use the NCCN name, branding, and products. EMD may not produce, publish, or distribute NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), NCCN Guidelines®: China Editions, NCCN Asia Consensus Statements, or any other NCCN materials or their derivatives. EMD is not authorized to organize, promote, or solicit sponsorship for any NCCN activity, including but not limited to the NCCN Guidelines: China Editions panel meetings, NCCN Asia Consensus Statements panel meetings, the NCCN Asia Scientific Congress, NCCN Global Leadership Exchange Program, and NCCN Symposia. NCCN is dedicated to continuing and enhancing its initiative in China in order to improve oncology practice to the benefit of Chinese patients with cancer.
View NCCN eBulletin Articles on international initiatives:
If you are a foreign citizen interested to attend one of our domestic educational programs and require a visa application letter from NCCN to travel, please contact Marisa Getzewich, Manager, Business Development. Please allow three weeks for processing of your request.
We welcome the opportunity to explore potential business collaborations with you.
If you have questions about NCCN international programs, please contact Jon Larsen, Manager, Global Business Development.
For general NCCN queries and domestic programs, please visit our main Contact Page.